Anti-tumor CD8+ T lymphocytes promote anti-tumor immunity via production of pro-inflammatory cytokines such as TNFα and IFNγ and direct perforin/granzyme-dependent killing of tumor cells. The gene discussed is PRF1; the disease is neoplasm.